Hims & Hers Health Retained Earnings (Accumulated Deficit) 2020-2025 | HIMS
Hims & Hers Health retained earnings (accumulated deficit) from 2020 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Hims & Hers Health retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $-0.193B, a 46.04% decline year-over-year.
- Hims & Hers Health retained earnings (accumulated deficit) for 2024 were $-0.242B, a 34.23% decline from 2023.
- Hims & Hers Health retained earnings (accumulated deficit) for 2023 were $-0.368B, a 6.83% increase from 2022.
- Hims & Hers Health retained earnings (accumulated deficit) for 2022 were $-0.345B, a 23.54% increase from 2021.
| Hims & Hers Health Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-242 |
| 2023 | $-368 |
| 2022 | $-345 |
| 2021 | $-279 |
| 2020 | $-171 |
| 2019 | $5 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-193 |
| 2024-12-31 | $-242 |
| 2024-09-30 | $-268 |
| 2024-06-30 | $-344 |
| 2024-03-31 | $-357 |
| 2023-12-31 | $-368 |
| 2023-09-30 | $-369 |
| 2023-06-30 | $-362 |
| 2023-03-31 | $-355 |
| 2022-12-31 | $-345 |
| 2022-09-30 | $-334 |
| 2022-06-30 | $-315 |
| 2022-03-31 | $-295 |
| 2021-12-31 | $-279 |
| 2021-09-30 | $-248 |
| 2021-06-30 | $-232 |
| 2021-03-31 | $-223 |
| 2020-12-31 | $-171 |
| 2020-09-30 | $0 |
| 2020-06-30 | $2 |
| 2020-03-31 | $2 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.608B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.427B | 59.33 |
| Tempus AI (TEM) | United States | $10.745B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.683B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.012B | 62.68 |
| Hinge Health (HNGE) | United States | $3.034B | 0.00 |
| Privia Health (PRVA) | United States | $2.827B | 193.25 |
| Enovis (ENOV) | United States | $1.816B | 10.12 |
| Schrodinger (SDGR) | United States | $1.807B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.555B | 0.00 |
| Omnicell (OMCL) | United States | $1.452B | 25.62 |
| Azenta (AZTA) | United States | $1.316B | 61.17 |
| 10x Genomics (TXG) | United States | $1.160B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.550B | 164.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| Outset Medical (OM) | United States | $0.371B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 794.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.142B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.52 |
| 111 (YI) | China | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |